|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 31/44 | |
| A61K 31/535 | |||
| A61K 31/65 | |||
| A61K 31/435 | |||
| A61K 31/505 | |||
| A61K 31/47 |
| (11) | Patento numeris | 1769795 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 06023696.5 |
| Europos patento paraiškos padavimo data | 2002-12-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-04-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-07-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 334609 P | 2001-12-03 | US |
| (72) |
Carter, Christopher A., US
Gibson, Neil, US
Hibner, Barbara, US
Humphrey, Rachel W., US
Trail, Pamela, US
Vincent, Patrick W., US
Zhai, Yifan, US
|
| (73) |
Bayer HealthCare LLC,
555 White Plains Road, Tarrytown, NY 10591,
US
|
| (54) | Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
| Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |